{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:47:22Z","timestamp":1793144842968,"version":"4.5.0"},"reference-count":290,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":2877,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s13311-015-0377-3","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T12:05:00Z","timestamp":1439294700000},"page":"699-730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":535,"title":["Molecular Targets of Cannabidiol in Neurological Disorders"],"prefix":"10.1016","volume":"12","author":[{"given":"Clementino","family":"Ibeas Bih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair V.W.","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Bazelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-015-0377-3_bib1","first-page":"344","article-title":"Marijuana in ancient Greece and Rome? The literary evidence","volume":"47","author":"Brunner","year":"1973","journal-title":"Bull Hist Med"},{"key":"10.1007\/s13311-015-0377-3_bib2","unstructured":"Dark P. The environment of Britain in the first millennium AD. UK: Bloomsbury Academic Press, 2000."},{"key":"10.1007\/s13311-015-0377-3_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF02862859","article-title":"An archaeological and historical account of cannabis in China","volume":"28","author":"Li","year":"1973","journal-title":"Econ Bot"},{"key":"10.1007\/s13311-015-0377-3_bib4","unstructured":"Manniche L. An ancient Egyptian herbal. British Museum Press."},{"key":"10.1007\/s13311-015-0377-3_bib5","unstructured":"Mathre ML. Cannabis in medical practice: a legal, historical and pharmacological overview of the therapeutic use of marijuana. McFarland & Co Inc., Jefferson, NC. USA, 1997."},{"key":"10.1007\/s13311-015-0377-3_bib6","first-page":"34","article-title":"Marijuana in medicine: past, present and future","volume":"110","author":"Mikuriya","year":"1969","journal-title":"Calif Med"},{"key":"10.1007\/s13311-015-0377-3_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/02791072.1985.10472336","article-title":"Thandai and chilam: traditional Hindu beliefs about the proper uses of Cannabis","volume":"17","author":"Morningstar","year":"1985","journal-title":"J Psychoactive Drugs"},{"key":"10.1007\/s13311-015-0377-3_bib8","unstructured":"Pollington S. Leechcraft: early English charms, plant lore, and healing. Anglo-Saxon Books. UK, 2000."},{"key":"10.1007\/s13311-015-0377-3_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02791072.1981.10471447","article-title":"The religious and medicinal uses of Cannabis in China, India and Tibet","volume":"13","author":"Touw","year":"1981","journal-title":"J Psychoactive Drugs"},{"key":"10.1007\/s13311-015-0377-3_bib10","doi-asserted-by":"crossref","unstructured":"Mecha M, Feli\u00fa A, I\u00f1igo PM, Mestre L, Carrillo-Salinas FJ, Guaza C. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Neurobiol Dis 2013;59:141-150.","DOI":"10.1016\/j.nbd.2013.06.016"},{"key":"10.1007\/s13311-015-0377-3_bib11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/j.1532-2149.2013.00445.x","article-title":"A double-blind, randomized, placebo-controlled, parallel group study of THC\/CBD spray in peripheral neuropathic pain treatment","volume":"18","author":"Serpell","year":"2014","journal-title":"Eur J Pain"},{"key":"10.1007\/s13311-015-0377-3_bib12","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1007\/s13311-015-0377-3_bib13","unstructured":"Pertwee R. Handbook of cannabis. Oxford University Press."},{"key":"10.1007\/s13311-015-0377-3_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.yebeh.2013.08.037","article-title":"Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy","volume":"29","author":"Porter","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-015-0377-3_bib15","unstructured":"GW Pharma. GW Pharmaceuticals provides update on Epidiolex\u00ae program in treatment-resistant childhood epilepsies. Available at: http:\/\/www.gwpharm.com\/GW%20Pharmaceuticals%20Provides%20Update%20on%20Epidiolex%20Program%20in%20Treatment-Resistant%20Childhood%20Epilepsies.aspx. Accessed August 4, 2015."},{"key":"10.1007\/s13311-015-0377-3_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u0394(9)-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0377-3_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/1535-7163.MCT-12-0335","article-title":"COX-2 and PPAR-\u03b3 confer cannabidiol-induced apoptosis of human lung cancer cells","volume":"12","author":"Ramer","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1007\/s13311-015-0377-3_bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib20","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000201556","article-title":"The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function","volume":"83","author":"Ahrens","year":"2009","journal-title":"Pharmacology"},{"key":"10.1007\/s13311-015-0377-3_bib22","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.20120242","article-title":"Cannabinoids suppress inflammatory and neuropathic pain by targeting \u03b13 glycine receptors","volume":"209","author":"Xiong","year":"2012","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-015-0377-3_bib23","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1476-5381.2012.02019.x","article-title":"GPR18 in microglia: implications for the CNS and endocannabinoid system signalling","volume":"167","author":"McHugh","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib24","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1073\/pnas.0902743106","article-title":"The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo","volume":"106","author":"Whyte","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0377-3_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuropharm.2013.03.029","article-title":"A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice","volume":"71","author":"Li","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-015-0377-3_bib26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1007\/s13311-015-0377-3_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejphar.2013.10.011","article-title":"Effects of cannabidiol on the function of \u03b17-nicotinic acetylcholine receptors","volume":"720","author":"Mahgoub","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","article-title":"Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn. Schmiedebergs Arch Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-015-0377-3_bib32","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"J\u00e1rai","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0377-3_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bcp.2013.11.016","article-title":"Increase of mesenchymal stem cell migration by cannabidiol via activation of p42\/44 MAPK","volume":"87","author":"Schmuhl","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib34","doi-asserted-by":"crossref","first-page":"H1141","DOI":"10.1152\/ajpheart.00754.2008","article-title":"Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine","volume":"296","author":"Yang","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1007\/s13311-015-0377-3_bib35","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1523\/JNEUROSCI.5066-06.2007","article-title":"Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study","volume":"27","author":"Elmenhorst","year":"2007","journal-title":"J. Neurosci. Off J Soc Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1074248414532013","article-title":"The effect of cannabidiol on ischemia\/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors","volume":"20","author":"Gonca","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1007\/s13311-015-0377-3_bib37","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1167\/iovs.08-2196","article-title":"Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor","volume":"49","author":"Liou","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1007\/s13311-015-0377-3_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib39","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1152\/physrev.00042.2003","article-title":"Molecular structure and function of the glycine receptor chloride channel","volume":"84","author":"Lynch","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1007\/s13311-015-0377-3_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nn.3615","article-title":"Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease","volume":"17","author":"Xiong","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.410410311","article-title":"Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography","volume":"41","author":"Madar","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-015-0377-3_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib43","doi-asserted-by":"crossref","unstructured":"Soares V de P, Campos AC, Bortoli VC de, Zangrossi H Jr, Guimar\u00e3es FS, Zuardi AW. Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors. Behav Brain Res 2010;213:225-229.","DOI":"10.1016\/j.bbr.2010.05.004"},{"key":"10.1007\/s13311-015-0377-3_bib44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/jpet.109.162594","article-title":"The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes","volume":"333","author":"Yang","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib46","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/syn.21665","article-title":"Evaluation of serotonin 5-HT1A receptors in rodent models using [18F]Mefway PET","volume":"67","author":"Saigal","year":"2013","journal-title":"Synapse"},{"key":"10.1007\/s13311-015-0377-3_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2013.09.006","article-title":"Endocannabinoids blunt the augmentation of synaptic transmission by serotonin 2A receptors in the nucleus tractus solitarii (nTS)","volume":"1537","author":"Austgen","year":"2013","journal-title":"Brain Res"},{"key":"10.1007\/s13311-015-0377-3_bib48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00213-006-0490-4","article-title":"WAY-100635 is a potent dopamine D4 receptor agonist","volume":"188","author":"Chemel","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0377-3_bib49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.phrs.2010.05.003","article-title":"Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors","volume":"62","author":"Alves","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1007\/s13311-015-0377-3_bib50","doi-asserted-by":"crossref","unstructured":"Gomes FV, Alves FHF, Guimar\u00e3es FS, Correa FMA, Resstel LBM, Crestani CC. Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptor. Eur. Neuropsychopharmacol 2013;23:1096-1104.","DOI":"10.1016\/j.euroneuro.2012.09.007"},{"key":"10.1007\/s13311-015-0377-3_bib51","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1073\/pnas.1211204110","article-title":"Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses","volume":"110","author":"Sylantyev","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0377-3_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2005.11.003","article-title":"In silico patent searching reveals a new cannabinoid receptor","volume":"27","author":"Baker","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1007\/s13311-015-0377-3_bib53","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbrc.2007.08.078","article-title":"Identification of GPR55 as a lysophosphatidylinositol receptor","volume":"362","author":"Oka","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-015-0377-3_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2009.03.010","article-title":"Time-dependent vascular actions of cannabidiol in the rat aorta","volume":"612","author":"O'Sullivan","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib55","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.lfs.2008.09.011","article-title":"Generation of reactive oxygen species during mouse hepatic microsomal metabolism of cannabidiol and cannabidiol hydroxy-quinone","volume":"83","author":"Usami","year":"2008","journal-title":"Life Sci"},{"key":"10.1007\/s13311-015-0377-3_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/03602530902843483","article-title":"Polymorphism of human cytochrome P450 enzymes and its clinical impact","volume":"41","author":"Zhou","year":"2009","journal-title":"Drug Metab Rev"},{"key":"10.1007\/s13311-015-0377-3_bib57","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2133\/dmpk.DMPK-12-RG-129","article-title":"Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19","volume":"28","author":"Jiang","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1007\/s13311-015-0377-3_bib58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/dmd.114.061242","article-title":"Differential expression of cytochrome P450 enzymes from the CYP2C subfamily in the human brain","volume":"43","author":"Booth Depaz","year":"2015","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"10.1007\/s13311-015-0377-3_bib59","first-page":"BR174","article-title":"Differences in cytochrome P450 2C19 (CYP2C19) expression in adjacent normal and tumor tissues in Chinese cancer patients","volume":"12","author":"Wu","year":"2006","journal-title":"Med Sci Monit"},{"key":"10.1007\/s13311-015-0377-3_bib60","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1124\/dmd.111.041384","article-title":"Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6","volume":"39","author":"Yamaori","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1007\/s13311-015-0377-3_bib61","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2133\/dmpk.DMPK-11-RG-107","article-title":"Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity","volume":"27","author":"Yamaori","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1007\/s13311-015-0377-3_bib62","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2010.01.028","article-title":"Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes","volume":"79","author":"Yamaori","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib63","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.lfs.2011.02.017","article-title":"Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety","volume":"88","author":"Yamaori","year":"2011","journal-title":"Life Sci"},{"key":"10.1007\/s13311-015-0377-3_bib64","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/01.ATV.1.6.449","article-title":"Cannabinoids impair the formation of cholesteryl ester in cultured human cells","volume":"1","author":"Cornicelli","year":"1981","journal-title":"Arteriosclerosis"},{"key":"10.1007\/s13311-015-0377-3_bib65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1471-4159.2006.03873.x","article-title":"Cannabinoids attenuate norepinephrine-induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N-acetyltransferase activity without involvement of cannabinoid receptors","volume":"98","author":"Koch","year":"2006","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-015-0377-3_bib66","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.toxlet.2014.09.002","article-title":"Cannabinoid-induced changes in respiration of brain mitochondria","volume":"231","author":"Fi\u0161ar","year":"2014","journal-title":"Toxicol Lett"},{"key":"10.1007\/s13311-015-0377-3_bib67","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1590\/1516-4446-2012-0886","article-title":"Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain","volume":"35","author":"Valvassori","year":"2013","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1007\/s13311-015-0377-3_bib68","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1471-4159.2007.05073.x","article-title":"5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid","volume":"104","author":"Massi","year":"2008","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-015-0377-3_bib69","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1248\/bpb.34.774","article-title":"Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa","volume":"34","author":"Ruhaak","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1007\/s13311-015-0377-3_bib70","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1248\/bpb.b13-00183","article-title":"Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety","volume":"36","author":"Yamaori","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"10.1007\/s13311-015-0377-3_bib71","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2008.12.004","article-title":"Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro","volume":"207","author":"Jenny","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-015-0377-3_bib73","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1124\/dmd.109.026930","article-title":"Cannabidiol-2\u2018,6\u2018-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor","volume":"37","author":"Takeda","year":"2009","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"10.1007\/s13311-015-0377-3_bib74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-5793(87)81420-5","article-title":"Activation of phospholipase A2 by cannabinoids. Lack of correlation with CNS effects","volume":"211","author":"Evans","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1007\/s13311-015-0377-3_bib75","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tox.2004.08.005","article-title":"Marijuana extracts possess the effects like the endocrine disrupting chemicals","volume":"206","author":"Watanabe","year":"2005","journal-title":"Toxicology"},{"key":"10.1007\/s13311-015-0377-3_bib76","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0006-291X(84)90702-2","article-title":"Stimulation of sphingomyelin hydrolysis by cannabidiol in fibroblasts from a Niemann-Pick patient","volume":"121","author":"Burstein","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-015-0377-3_bib77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2011.05.018","article-title":"Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes","volume":"89","author":"Jiang","year":"2011","journal-title":"Life Sci"},{"key":"10.1007\/s13311-015-0377-3_bib78","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation","volume":"85","author":"Bryan","year":"2013","journal-title":"Biochem. Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061462","article-title":"Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells","volume":"8","author":"Juknat","year":"2013","journal-title":"PloS One"},{"key":"10.1007\/s13311-015-0377-3_bib80","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0006-291X(03)00763-0","article-title":"Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms. Biochem","volume":"305","author":"Bock","year":"2003","journal-title":"Biophys Res Commun"},{"key":"10.1007\/s13311-015-0377-3_bib81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-5793(02)03489-0","article-title":"Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?","volume":"531","author":"Cremesti","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1007\/s13311-015-0377-3_bib82","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0006-291X(82)92113-1","article-title":"In situ degradation of sphingomyelin by cultured normal fibroblasts and fibroblasts from patients with Niemann-Pick disease type A and C","volume":"108","author":"Maziere","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-015-0377-3_bib83","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.103.061002","article-title":"Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines","volume":"308","author":"Massi","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.471","article-title":"Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death","volume":"4","author":"Rimmerman","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1007\/s13311-015-0377-3_bib85","first-page":"164","article-title":"VDAC1: from structure to cancer therapy","volume":"2","author":"Shoshan-Barmatz","year":"2012","journal-title":"Mol Cell Oncol"},{"key":"10.1007\/s13311-015-0377-3_bib86","doi-asserted-by":"crossref","unstructured":"Singh N, Hroudov\u00e1 J, Fi\u0161ar Z. Cannabinoid-induced changes in the activity of electron transport chain complexes of brain mitochondria. J Mol Neurosci 2015 Mar 29 [Epub ahead of print].","DOI":"10.1007\/s12031-015-0545-2"},{"key":"10.1007\/s13311-015-0377-3_bib87","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2826.2004.01250.x","article-title":"Mechanisms of N-methyl-D-aspartate receptor inhibition by melatonin in the rat striatum","volume":"16","author":"Escames","year":"2004","journal-title":"J Neuroendocrinol"},{"key":"10.1007\/s13311-015-0377-3_bib88","doi-asserted-by":"crossref","unstructured":"Ozkanlar S, Kara A, Sengul E, Simsek N, Karadeniz A, Kurt N. Melatonin modulates the immune system response and inflammation in diabetic rats experimentally-induced by alloxan. Horm Metab Res 2015 May 4 [Epub ahead of print].","DOI":"10.1055\/s-0035-1548937"},{"key":"10.1007\/s13311-015-0377-3_bib89","doi-asserted-by":"crossref","unstructured":"Ramis MR, Esteban S, Miralles A, Tan D-X, Reiter RJ. Protective effects of melatonin and mitochondria-targeted antioxidants against oxidative stress: a review. Curr Med Chem 2015 Jun 18 [Epub ahead of print].","DOI":"10.2174\/0929867322666150619104143"},{"key":"10.1007\/s13311-015-0377-3_bib90","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12017-009-8092-z","article-title":"Phospholipases A2 and inflammatory responses in the central nervous system","volume":"12","author":"Sun","year":"2010","journal-title":"Neuromolecular Med"},{"key":"10.1007\/s13311-015-0377-3_bib91","first-page":"97","article-title":"Search for a \u201ctoxic site\u201d in snake venom phospholipases A2","volume":"22","author":"Arriagada","year":"1989","journal-title":"Arch Biol Med Exp"},{"key":"10.1007\/s13311-015-0377-3_bib92","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/nu2030355","article-title":"Omega-3 fatty acids and inflammatory processes","volume":"2","author":"Calder","year":"2010","journal-title":"Nutrients"},{"key":"10.1007\/s13311-015-0377-3_bib93","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/jpet.114.217125","article-title":"Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation","volume":"351","author":"Wheal","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib94","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbi.2014.06.200","article-title":"Insights from interferon-\u03b1-related depression for the pathogenesis of depression associated with inflammation","volume":"42","author":"Hoyo-Becerra","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1007\/s13311-015-0377-3_bib95","doi-asserted-by":"crossref","first-page":"16124","DOI":"10.1074\/jbc.M707104200","article-title":"Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol","volume":"283","author":"Ross","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-015-0377-3_bib96","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","article-title":"TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons","volume":"28","author":"Qin","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib97","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1124\/jpet.107.134809","article-title":"Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8","volume":"325","author":"De Petrocellis","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib98","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib99","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/carcin\/bgs328","article-title":"Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents","volume":"34","author":"Nabissi","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1007\/s13311-015-0377-3_bib101","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1748-1716.2011.02338.x","article-title":"Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation","volume":"204","author":"De Petrocellis","year":"2012","journal-title":"Acta Physiol"},{"key":"10.1007\/s13311-015-0377-3_bib102","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/SLA.0b013e3182a6359c","article-title":"Transient receptor potential ion channels: powerful regulators of cell function","volume":"259","author":"Billeter","year":"2014","journal-title":"Ann Surg"},{"key":"10.1007\/s13311-015-0377-3_bib103","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2008.06.079","article-title":"Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1)","volume":"591","author":"Holland","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib104","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjp.0707467","article-title":"The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids","volume":"152","author":"Holland","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib105","doi-asserted-by":"crossref","unstructured":"Pandolfo P, Silveirinha V, Santos-Rodrigues A dos, et al. Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum. Eur J Pharmacol 2011;655:38-45.","DOI":"10.1016\/j.ejphar.2011.01.013"},{"key":"10.1007\/s13311-015-0377-3_bib106","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0377-3_bib107","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1476-5381.1977.tb07727.x","article-title":"Effects of delta9-tetrahydrocannabinol and cannabidiol on a Mg2+-ATPase of synaptic vesicles prepared from rat cerebral cortex","volume":"59","author":"Gilbert","year":"1977","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib108","doi-asserted-by":"crossref","unstructured":"Coyle JT, and Snyder SHJ. Catecholamine uptake by synaptosomes in homogenates of rat brain: Stereospecificity in different areas. Pharmacol Exp Ther 1969;170:221.","DOI":"10.1016\/S0022-3565(25)28416-6"},{"key":"10.1007\/s13311-015-0377-3_bib109","doi-asserted-by":"crossref","unstructured":"Whittaker VP, Michaelson IA, Kirkland RJA. The separation of synaptic vesicles from nerve-ending particles (\u2018synaptosomes\u2018). Biochem J 1964;90:293-303.","DOI":"10.1042\/bj0900293"},{"key":"10.1007\/s13311-015-0377-3_bib110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"key":"10.1007\/s13311-015-0377-3_bib111","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1002\/ijc.28591","article-title":"The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2","volume":"134","author":"Morelli","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1007\/s13311-015-0377-3_bib112","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mam.2010.03.002","article-title":"VDAC, a multi-functional mitochondrial protein regulating cell life and death","volume":"31","author":"Shoshan-Barmatz","year":"2010","journal-title":"Mol Aspects Med"},{"key":"10.1007\/s13311-015-0377-3_bib113","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neulet.2014.03.013","article-title":"Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se","volume":"566","author":"Hill","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-015-0377-3_bib114","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1152\/physrev.00007.2013","article-title":"Mechanisms of glutamate transport","volume":"93","author":"Vandenberg","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1007\/s13311-015-0377-3_bib115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3565(25)30230-2","article-title":"Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes","volume":"194","author":"Banerjee","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib116","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3565(25)32131-2","article-title":"Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes","volume":"214","author":"Poddar","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib117","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0022-3565(25)32047-1","article-title":"Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus","volume":"213","author":"Lindamood","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib118","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(24)35376-5","article-title":"Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells","volume":"292","author":"Rakhshan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib119","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1248\/bpb.19.1109","article-title":"Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids","volume":"19","author":"Watanabe","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1007\/s13311-015-0377-3_bib120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0090-6980(00)00054-X","article-title":"Cannabimimetic fatty acid derivatives in cancer and inflammation","volume":"61","author":"Di Marzo","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1007\/s13311-015-0377-3_bib121","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/jpet.105.098541","article-title":"Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana","volume":"317","author":"Zhu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib122","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.clinbiochem.2005.02.005","article-title":"Magnesium sulfate effect on erythrocyte membranes of asphyxiated newborns","volume":"38","author":"Szemraj","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1007\/s13311-015-0377-3_bib123","doi-asserted-by":"crossref","first-page":"g254","DOI":"10.1136\/bmj.g254","article-title":"Drug treatment of epilepsy in adults","volume":"348","author":"Schmidt","year":"2014","journal-title":"BMJ"},{"key":"10.1007\/s13311-015-0377-3_bib124","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-015-0377-3_bib125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.braindev.2012.04.007","article-title":"Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb","volume":"35","author":"Shu","year":"2013","journal-title":"Brain Dev"},{"key":"10.1007\/s13311-015-0377-3_bib126","doi-asserted-by":"crossref","unstructured":"R\u00fcden EL von, Jafari M, Bogdanovic RM, Wotjak CT, Potschka H. Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm. Neurobiol Dis 2015;73:334-347.","DOI":"10.1016\/j.nbd.2014.08.001"},{"key":"10.1007\/s13311-015-0377-3_bib127","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2011.03.041","article-title":"Post-ictal analgesia in genetically epilepsy-prone rats is induced by audiogenic seizures and involves cannabinoid receptors in the periaqueductal gray","volume":"1389","author":"Samineni","year":"2011","journal-title":"Brain Res"},{"key":"10.1007\/s13311-015-0377-3_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010683","article-title":"Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy","volume":"5","author":"Bhaskaran","year":"2010","journal-title":"PloS One"},{"key":"10.1007\/s13311-015-0377-3_bib129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2013.07.041","article-title":"Piperine exerts anti-seizure effects via the TRPV1 receptor in mice","volume":"714","author":"Chen","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11011-014-9549-9","article-title":"Electromagnetic radiation (Wi-Fi) and epilepsy induce calcium entry and apoptosis through activation of TRPV1 channel in hippocampus and dorsal root ganglion of rats","volume":"29","author":"Ghazizadeh","year":"2014","journal-title":"Metab Brain Dis"},{"key":"10.1007\/s13311-015-0377-3_bib131","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.expneurol.2013.10.010","article-title":"TRPV1 antagonist capsazepine suppresses 4-AP-induced epileptiform activity in vitro and electrographic seizures in vivo","volume":"250","author":"Gonzalez-Reyes","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-015-0377-3_bib132","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2012.02.003","article-title":"Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures","volume":"100","author":"Manna","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-015-0377-3_bib133","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00232-014-9744-y","article-title":"Epilepsy but not mobile phone frequency (900 MHz) induces apoptosis and calcium entry in hippocampus of epileptic rat: involvement of TRPV1 channels","volume":"248","author":"Naz\u0131ro\u011flu","year":"2015","journal-title":"J Membr Biol"},{"key":"10.1007\/s13311-015-0377-3_bib134","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s10072-014-1689-5","article-title":"Involvement of central TRPV1 receptors in pentylenetetrazole and amygdala-induced kindling in male rats","volume":"35","author":"Shirazi","year":"2014","journal-title":"Neurol Sci"},{"key":"10.1007\/s13311-015-0377-3_bib135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.yebeh.2013.10.022","article-title":"Role of TRPV1 in susceptibility to PTZ-induced seizure following repeated hyperthermia challenges in neonatal mice","volume":"31","author":"Kong","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-015-0377-3_bib136","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.expneurol.2012.06.013","article-title":"A novel zebrafish model of hyperthermia-induced seizures reveals a role for TRPV4 channels and NMDA-type glutamate receptors","volume":"237","author":"Hunt","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-015-0377-3_bib137","doi-asserted-by":"crossref","first-page":"493480","DOI":"10.1155\/2014\/493480","article-title":"Auricular electroacupuncture reduced inflammation-related epilepsy accompanied by altered TRPA1, pPKC\u03b1, pPKC\u03b5, and pERk1\/2 signaling pathways in kainic acid-treated rats","volume":"2014","author":"Lin","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1007\/s13311-015-0377-3_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013513","article-title":"Regionalized pathology correlates with augmentation of mtDNA copy numbers in a patient with myoclonic epilepsy with ragged-red fibers (MERRF-syndrome)","volume":"5","author":"Brinckmann","year":"2010","journal-title":"PloS One"},{"key":"10.1007\/s13311-015-0377-3_bib139","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/jnr.21384","article-title":"Preliminary explorations of the role of mitochondrial proteins in refractory epilepsy: some findings from comparative proteomics","volume":"85","author":"Jiang","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-015-0377-3_bib140","doi-asserted-by":"crossref","first-page":"768594","DOI":"10.1155\/2014\/768594","article-title":"Role of PPAR \u03b3 in the differentiation and function of neurons","volume":"2014","author":"Quintanilla","year":"2014","journal-title":"PPAR Res"},{"key":"10.1007\/s13311-015-0377-3_bib141","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1734-1140(13)71060-0","article-title":"Research advances in basic mechanisms of seizures and antiepileptic drug action","volume":"65","author":"Laso\u0144","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1007\/s13311-015-0377-3_bib142","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-4020-6191-2_8","article-title":"Calcium channelopathies: voltage-gated calcium channels","volume":"45","author":"Adams","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1007\/s13311-015-0377-3_bib143","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1124\/mol.60.5.1121","article-title":"Block of cloned human T-type calcium channels by succinimide antiepileptic drugs","volume":"60","author":"Gomora","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib144","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1528-1167.2012.03495.x","article-title":"Successful use of fenfluramine as an add-on treatment for Dravet syndrome","volume":"53","author":"Ceulemans","year":"2012","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-015-0377-3_bib145","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1528-1167.2007.01089.x","article-title":"Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy","volume":"48","author":"Theodore","year":"2007","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-015-0377-3_bib146","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1528-1167.2011.03309.x","article-title":"Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy","volume":"53","author":"Theodore","year":"2012","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-015-0377-3_bib147","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fncel.2013.00184","article-title":"Glycine receptors and brain development","volume":"7","author":"Avila","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.02.001.2008","article-title":"A critical role for glycine transporters in hyperexcitability disorders","volume":"1","author":"Harvey","year":"2008","journal-title":"Front Mol Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib149","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pharmthera.2013.06.003","article-title":"Delta opioid receptors in brain function and diseases","volume":"140","author":"Chu Sin Chung","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1007\/s13311-015-0377-3_bib150","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0014-4886(86)90195-0","article-title":"Opiate-induced seizures: a study of mu and delta specific mechanisms","volume":"93","author":"Snead","year":"1986","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-015-0377-3_bib151","first-page":"413","article-title":"In vivo and in vitro epileptogenic effects of the enkephalinergic system","volume":"29","author":"Sagratella","year":"1993","journal-title":"Ann Ist Super Sanita"},{"key":"10.1007\/s13311-015-0377-3_bib152","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/revneuro-2013-0053","article-title":"Genetic background of febrile seizures","volume":"25","author":"Saghazadeh","year":"2014","journal-title":"Rev Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib153","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fphys.2015.00022","article-title":"The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy","volume":"6","author":"Becchetti","year":"2015","journal-title":"Front Physiol"},{"key":"10.1007\/s13311-015-0377-3_bib154","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tins.2012.12.003","article-title":"Adenosine: setting the stage for plasticity","volume":"36","author":"Dias","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pharep.2013.10.005","article-title":"Modulation of adenosinergic system and its application for the treatment of epilepsy","volume":"66","author":"\u015awi\u0105der","year":"2014","journal-title":"Pharmacol Rep"},{"key":"10.1007\/s13311-015-0377-3_bib156","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1389200013338513","article-title":"Cytochrome P450 in the brain; a review","volume":"2","author":"Hedlund","year":"2001","journal-title":"Curr Drug Metab"},{"key":"10.1007\/s13311-015-0377-3_bib157","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","article-title":"Altered lipid metabolism in brain injury and disorders","volume":"49","author":"Adibhatla","year":"2008","journal-title":"Subcell Biochem"},{"key":"10.1007\/s13311-015-0377-3_bib158","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/syn.20547","article-title":"Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid","volume":"62","author":"Coomber","year":"2008","journal-title":"Synapse"},{"key":"10.1007\/s13311-015-0377-3_bib159","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eplepsyres.2012.11.006","article-title":"Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats","volume":"104","author":"Vilela","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-015-0377-3_bib160","first-page":"589","article-title":"Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors","volume":"66","author":"Villikka","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1007\/s13311-015-0377-3_bib161","doi-asserted-by":"crossref","unstructured":"Geffrey AL, Pollack SF, Bruno PL, Thiele EA. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia 2015 Jun 26 [Epub ahead of print].","DOI":"10.1111\/epi.13060"},{"key":"10.1007\/s13311-015-0377-3_bib162","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2004.02355.x","article-title":"Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors","volume":"89","author":"Clinckers","year":"2004","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-015-0377-3_bib163","first-page":"706","article-title":"Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective","volume":"2011","author":"Zoerner","year":"1811","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-015-0377-3_bib164","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0028-3908(81)90006-X","article-title":"Intranigral injection of capsaicin enhances motor activity and depletes nigral 5-hydroxytryptamine but not substance P","volume":"20","author":"Dawbarn","year":"1981","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-015-0377-3_bib165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01244779","article-title":"Capsaicin-sensitive vasodilatatory mechanisms in the rat substantia nigra and striatum","volume":"74","author":"Haj\u00f3s","year":"1988","journal-title":"J Neural Transm"},{"key":"10.1007\/s13311-015-0377-3_bib166","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ncb2012","article-title":"PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1","volume":"12","author":"Geisler","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1007\/s13311-015-0377-3_bib167","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.biopsych.2009.05.006","article-title":"Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume","volume":"66","author":"Stone","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-015-0377-3_bib168","first-page":"287","article-title":"Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms","volume":"57","author":"Sramek","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s13311-015-0377-3_bib169","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ddr.20016","article-title":"5-HT2 receptors and anxiety","volume":"65","author":"Bourin","year":"2005","journal-title":"Drug Dev Res"},{"key":"10.1007\/s13311-015-0377-3_bib170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2125.1989.tb05347.x","article-title":"Effect of infused adenosine on cardiac output and systemic resistance in normal subjects","volume":"27","author":"Bush","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib171","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/gbb.12045","article-title":"CB1 receptor signaling regulates social anxiety and memory","volume":"12","author":"Litvin","year":"2013","journal-title":"Genes Brain Behav"},{"key":"10.1007\/s13311-015-0377-3_bib172","first-page":"41","article-title":"Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT1A receptors","volume":"18","author":"Mohajjel Nayebi","year":"2010","journal-title":"Daru"},{"key":"10.1007\/s13311-015-0377-3_bib173","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1523\/JNEUROSCI.06-05-01358.1986","article-title":"The glycine receptor deficiency of the mutant mouse spastic: evidence for normal glycine receptor structure and localization","volume":"6","author":"Becker","year":"1986","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib174","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/exnr.2001.7727","article-title":"Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"171","author":"Henry","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-015-0377-3_bib175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01213011-200503000-00003","article-title":"CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis","volume":"15","author":"Patsopoulos","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1007\/s13311-015-0377-3_bib176","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Li\u00e9vens","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-015-0377-3_bib177","first-page":"231","article-title":"Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders","volume":"56","author":"Kany\u00f3","year":"2003","journal-title":"Ideggyogy Sz"},{"key":"10.1007\/s13311-015-0377-3_bib178","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.euroneuro.2005.06.001","article-title":"UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay\/arrest the progression of different motor-related disorders","volume":"16","author":"de Lago","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib179","doi-asserted-by":"crossref","unstructured":"Pamplona FA, Ferreira J, Lima OM de, et al. Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor. Proc Natl Acad Sci 2012;109:21134-21139.","DOI":"10.1073\/pnas.1202906109"},{"key":"10.1007\/s13311-015-0377-3_bib180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuropharm.2007.06.005","article-title":"Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1\/2 MAP kinase signaling","volume":"54","author":"Daigle","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-015-0377-3_bib181","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-015-0377-3_bib182","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice","volume":"42","author":"Cheng","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-015-0377-3_bib183","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ceca.2012.04.015","article-title":"Mitochondrial Ca2+ and neurodegeneration","volume":"52","author":"Cal\u00ec","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1007\/s13311-015-0377-3_bib184","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.arr.2015.02.001","article-title":"Ageing and inflammation \u2013 a central role for mitochondria in brain health and disease","volume":"21","author":"Currais","year":"2015","journal-title":"Ageing Res Rev"},{"key":"10.1007\/s13311-015-0377-3_bib185","doi-asserted-by":"crossref","first-page":"484613","DOI":"10.1155\/2013\/484613","article-title":"Role of redox signaling in neuroinflammation and neurodegenerative diseases","volume":"2013","author":"Hsieh","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1007\/s13311-015-0377-3_bib186","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.arcmed.2012.11.003","article-title":"Epidemiology of dementias and Alzheimer's disease","volume":"43","author":"Sosa-Ortiz","year":"2012","journal-title":"Arch Med Res"},{"key":"10.1007\/s13311-015-0377-3_bib187","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1007\/s13311-015-0377-3_bib188","unstructured":"Latta CH, Brothers HM, Wilcock DM. Neuroinflammation in Alzheimer's disease; a source of heterogeneity and target for personalized therapy. Neuroscience 2014;pii:S0306-4522(14)00820-3."},{"key":"10.1007\/s13311-015-0377-3_bib189","first-page":"97","article-title":"Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities","volume":"11","author":"Lozano","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1007\/s13311-015-0377-3_bib190","first-page":"221","article-title":"The genetics of Leigh syndrome and its implications for clinical practice and risk management","volume":"7","author":"Ruhoy","year":"2014","journal-title":"Appl Clin Genet"},{"key":"10.1007\/s13311-015-0377-3_bib191","doi-asserted-by":"crossref","unstructured":"Heneka MT, Carson MJ, Khoury J El, et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol 2015;14:388-405.","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"10.1007\/s13311-015-0377-3_bib192","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5812\/ijhrba.9222","article-title":"The endocannabinoid system: a putative role in neurodegenerative diseases","volume":"2","author":"Di Iorio","year":"2013","journal-title":"Int J High Risk Behav Addict"},{"key":"10.1007\/s13311-015-0377-3_bib193","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1042\/BST20130140","article-title":"Endocannabinoid signalling in Alzheimer's disease","volume":"41","author":"Maroof","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"10.1007\/s13311-015-0377-3_bib194","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"290","author":"Elmes","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-015-0377-3_bib195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.02.002","article-title":"Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease","volume":"97","author":"Xu","year":"2012","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s13311-015-0377-3_bib196","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1476-5381.2009.00589.x","article-title":"Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation","volume":"159","author":"Magen","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib197","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-015-0377-3_bib198","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PloS One"},{"key":"10.1007\/s13311-015-0377-3_bib199","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1164\/rccm.200907-1047OC","article-title":"Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice","volume":"182","author":"Cho","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s13311-015-0377-3_bib200","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/j.1476-5381.2011.01461.x","article-title":"Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and \u03949-tetrahydrocannabinol in BV-2 microglial cells","volume":"165","author":"Juknat","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib201","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0377-3_bib202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1096\/fj.08-108670","article-title":"The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation","volume":"23","author":"Henstridge","year":"2009","journal-title":"FASEB J"},{"key":"10.1007\/s13311-015-0377-3_bib203","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1182\/blood-2012-02-404475","article-title":"NFAT control of innate immunity","volume":"120","author":"Fric","year":"2012","journal-title":"Blood"},{"key":"10.1007\/s13311-015-0377-3_bib204","doi-asserted-by":"crossref","first-page":"15331","DOI":"10.1523\/JNEUROSCI.4873-09.2009","article-title":"Nuclear factor of activated T-cells isoform c4 (NFATc4\/NFAT3) as a mediator of antiapoptotic transcription in NMDA receptor-stimulated cortical neurons","volume":"29","author":"Vashishta","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib205","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1523\/JNEUROSCI.4456-09.2010","article-title":"Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation","volume":"30","author":"Wu","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib206","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1523\/JNEUROSCI.1064-09.2009","article-title":"Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin\/NFAT signaling","volume":"29","author":"Abdul","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib207","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pnpbp.2014.05.011","article-title":"Targeting the \u03b17 nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down's syndrome","volume":"54","author":"Deutsch","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1007\/s13311-015-0377-3_bib208","doi-asserted-by":"crossref","unstructured":"Lombardo S, Maskos U. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment. Neuropharmacology 2015;96(Pt B):255-262.","DOI":"10.1016\/j.neuropharm.2014.11.018"},{"key":"10.1007\/s13311-015-0377-3_bib209","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0022-5347(25)00276-9","article-title":"Modulation of rat brain opioid receptors by cannabinoids","volume":"241","author":"Vaysse","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib210","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/138945012799201612","article-title":"Current research on opioid receptor function","volume":"13","author":"Feng","year":"2012","journal-title":"Curr Drug Targets"},{"key":"10.1007\/s13311-015-0377-3_bib211","doi-asserted-by":"crossref","unstructured":"Hroudov\u00e1 J, Singh N, Fi\u0161ar Z. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease. Biomed Res Int 2014;175062.","DOI":"10.1155\/2014\/175062"},{"key":"10.1007\/s13311-015-0377-3_bib212","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2203\/dose-response.13-035.Ristow","article-title":"Mitohormesis: promoting health and lifespan by increased levels of reactive oxygen species (ROS)","volume":"12","author":"Ristow","year":"2014","journal-title":"Dose Response"},{"key":"10.1007\/s13311-015-0377-3_bib213","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.mehy.2005.09.009","volume":"66","author":"Tapia","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1007\/s13311-015-0377-3_bib214","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pnpbp.2013.08.008","article-title":"Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis","volume":"48","author":"Myint","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1007\/s13311-015-0377-3_bib215","first-page":"104","article-title":"Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration","volume":"7","author":"Figueiredo-Pereira","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib216","first-page":"469","article-title":"Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance","volume":"2015","author":"Calder","year":"1851","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-015-0377-3_bib217","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.arr.2010.09.003","article-title":"Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease?","volume":"10","author":"Pomponi","year":"2011","journal-title":"Ageing Res Rev"},{"key":"10.1007\/s13311-015-0377-3_bib218","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/jpet.105.085779","article-title":"Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity","volume":"314","author":"Hamelink","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib219","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0377-3_bib220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garc\u00eda-Arencibia","year":"2007","journal-title":"Brain Res"},{"key":"10.1007\/s13311-015-0377-3_bib221","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-015-0377-3_bib222","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1124\/dmd.109.026898","article-title":"Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids","volume":"37","author":"Mazur","year":"2009","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"10.1007\/s13311-015-0377-3_bib223","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?","volume":"75","author":"Fern\u00e1ndez-Ruiz","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib224","first-page":"67","article-title":"Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?","volume":"2013","author":"Reddy","year":"1832","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-015-0377-3_bib225","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3233\/JAD-130761","article-title":"Reduced VDAC1 protects against Alzheimer's disease, mitochondria, and synaptic deficiencies","volume":"37","author":"Manczak","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-015-0377-3_bib226","first-page":"1745","article-title":"The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis","volume":"2013","author":"Keinan","year":"1833","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-015-0377-3_bib227","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cdd.2011.92","article-title":"VDAC1 selectively transfers apoptotic Ca2+ signals to mitochondria","volume":"19","author":"De Stefani","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1007\/s13311-015-0377-3_bib228","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/glia.21044","article-title":"Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes","volume":"58","author":"Mato","year":"2010","journal-title":"Glia"},{"key":"10.1007\/s13311-015-0377-3_bib229","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4212-08.2009","article-title":"Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels","volume":"29","author":"Ryan","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib230","first-page":"1","article-title":"TRPV1: a stress response protein in the central nervous system","volume":"1","author":"Ho","year":"2012","journal-title":"Am J Neurodegener Dis"},{"key":"10.1007\/s13311-015-0377-3_bib231","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/cr.2011.205","article-title":"TRPV1 activation improves exercise endurance and energy metabolism through PGC-1\u03b1 upregulation in mice","volume":"22","author":"Luo","year":"2012","journal-title":"Cell Res"},{"key":"10.1007\/s13311-015-0377-3_bib232","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1523\/JNEUROSCI.4810-07.2008","article-title":"Mechanisms of prolonged presynaptic Ca2+ signaling and glutamate release induced by TRPV1 activation in rat sensory neurons","volume":"28","author":"Medvedeva","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib233","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/iub.1131","article-title":"The control of brain mitochondrial energization by cytosolic calcium: the mitochondrial gas pedal","volume":"65","author":"Gellerich","year":"2013","journal-title":"IUBMB Life"},{"key":"10.1007\/s13311-015-0377-3_bib234","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pbb.2014.03.022","article-title":"Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington's disease","volume":"122","author":"Gupta","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1007\/s13311-015-0377-3_bib235","first-page":"1380","article-title":"Adenosine receptors and brain diseases: neuroprotection and neurodegeneration","volume":"2011","author":"Gomes","year":"1808","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-015-0377-3_bib236","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1479-7364-5-3-170","article-title":"The human fatty acid-binding protein family: evolutionary divergences and functions","volume":"5","author":"Smathers","year":"2011","journal-title":"Hum Genomics"},{"key":"10.1007\/s13311-015-0377-3_bib237","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000323417","article-title":"Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease","volume":"1","author":"Ohrfelt","year":"2011","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"10.1007\/s13311-015-0377-3_bib238","doi-asserted-by":"crossref","first-page":"18957","DOI":"10.1074\/jbc.M113.527341","article-title":"FABP3 protein promotes \u03b1-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity","volume":"289","author":"Shioda","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-015-0377-3_bib239","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.mad.2013.08.007","article-title":"Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain","volume":"134","author":"Pahnke","year":"2013","journal-title":"Mech Ageing Dev"},{"key":"10.1007\/s13311-015-0377-3_bib240","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1172\/JCI57867","article-title":"Cerebral amyloid-\u03b2 proteostasis is regulated by the membrane transport protein ABCC1 in mice","volume":"121","author":"Krohn","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-015-0377-3_bib241","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1523\/JNEUROSCI.5103-08.2009","article-title":"ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides","volume":"29","author":"Xiong","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib242","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","article-title":"Is dopamine involved in Alzheimer's disease?","volume":"6","author":"Martorana","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib243","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.neuint.2012.01.017","article-title":"Metabotropic glutamate receptors in neurodegeneration\/neuroprotection: still a hot topic?","volume":"61","author":"Caraci","year":"2012","journal-title":"Neurochem Int"},{"key":"10.1007\/s13311-015-0377-3_bib244","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-90-481-8622-8_7","article-title":"High density lipoprotein structure-function and role in reverse cholesterol transport","volume":"51","author":"Lund-Katz","year":"2010","journal-title":"Subcell Biochem"},{"issue":"Suppl. 2","key":"10.1007\/s13311-015-0377-3_bib245","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.neurobiolaging.2014.03.037","article-title":"Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease","volume":"35","author":"Poirier","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"2 Suppl.","key":"10.1007\/s13311-015-0377-3_bib246","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1007\/s13311-015-0377-3_bib247","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"10.1007\/s13311-015-0377-3_bib248","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","article-title":"Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation","volume":"143","author":"Costa","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib249","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","article-title":"The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain","volume":"556","author":"Costa","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib250","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1476-5381.2010.01063.x","article-title":"Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action","volume":"162","author":"Maione","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib251","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1213\/ANE.0b013e3182283486","article-title":"Cannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female C57Bl6 mice","volume":"113","author":"Ward","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1007\/s13311-015-0377-3_bib252","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.12439","article-title":"Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy","volume":"171","author":"Ward","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib253","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1631\/jzus.B1400189","article-title":"Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice","volume":"16","author":"Sa\u0142at","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1007\/s13311-015-0377-3_bib254","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/sj.bjp.0706798","article-title":"AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain","volume":"148","author":"Costa","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib255","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00210-015-1090-9","article-title":"AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia","volume":"388","author":"Lehto","year":"2015","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib256","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/art.39094","article-title":"Suppression of peripheral pain by blockade of Cav2.2 channels in nociceptors induces RANKL and impairs recovery from inflammatory arthritis","volume":"67","author":"Baddack","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1007\/s13311-015-0377-3_bib257","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/bph.12251","article-title":"Spinal actions of \u03c9-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model","volume":"170","author":"Jayamanne","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib258","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/j.1532-2149.2013.00439.x","article-title":"Norisoboldine attenuates inflammatory pain via the adenosine A1 receptor","volume":"18","author":"Gao","year":"2014","journal-title":"Eur J Pain"},{"key":"10.1007\/s13311-015-0377-3_bib259","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.neuroscience.2010.07.045","article-title":"Peripheral adenosine A2A receptors are involved in carrageenan-induced mechanical hyperalgesia in mice","volume":"170","author":"Li","year":"2010","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-015-0377-3_bib260","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0022-3565(25)20660-7","article-title":"WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135","volume":"278","author":"Fornal","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0377-3_bib261","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2008.04.006","article-title":"The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain","volume":"139","author":"Staton","year":"2008","journal-title":"Pain"},{"key":"10.1007\/s13311-015-0377-3_bib262","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2119\/molmed.2014.00143","article-title":"Stimulation of the alpha 7 nicotinic acetylcholine receptor protects against neuroinflammation after tibia fracture and endotoxemia in mice","volume":"20","author":"Terrando","year":"2015","journal-title":"Mol Med"},{"key":"10.1007\/s13311-015-0377-3_bib263","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.bcp.2013.06.018","article-title":"Functional role of alpha7 nicotinic receptor in chronic neuropathic and inflammatory pain: Studies in transgenic mice","volume":"86","author":"AlSharari","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib264","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.toxicon.2014.11.222","article-title":"Nicotinic acetylcholine receptor \u03b17 subunit is involved in the cobratoxin-induced antinociception in an animal model of neuropathic pain","volume":"93","author":"Gong","year":"2015","journal-title":"Toxicon"},{"key":"10.1007\/s13311-015-0377-3_bib265","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2014.12.002","article-title":"The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor","volume":"91","author":"Papke","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-015-0377-3_bib266","doi-asserted-by":"crossref","unstructured":"Hasani R Al-, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 2011;115:1363-1381.","DOI":"10.1097\/ALN.0b013e318238bba6"},{"key":"10.1007\/s13311-015-0377-3_bib267","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"10.1007\/s13311-015-0377-3_bib268","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2133\/dmpk.DMPK-13-RV-032","article-title":"Influence of Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics","volume":"29","author":"Zahari","year":"2014","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1007\/s13311-015-0377-3_bib269","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.pnpbp.2009.08.017","article-title":"Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids","volume":"33","author":"Campos","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1007\/s13311-015-0377-3_bib270","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1096\/fj.07-101865","article-title":"Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain","volume":"22","author":"Moussaieff","year":"2008","journal-title":"FASEB J"},{"key":"10.1007\/s13311-015-0377-3_bib271","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.neuropharm.2010.11.015","article-title":"T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats","volume":"62","author":"Uslaner","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-015-0377-3_bib272","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnbeh.2014.00092","article-title":"T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants","volume":"8","author":"Gangarossa","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib273","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/FBP.0b013e3283566082","article-title":"Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer's disease","volume":"23","author":"Price","year":"2012","journal-title":"Behav Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib274","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000107687","article-title":"Taurine induces anti-anxiety by activating strychnine-sensitive glycine receptor in vivo","volume":"51","author":"Zhang","year":"2007","journal-title":"Ann Nutr Metab"},{"key":"10.1007\/s13311-015-0377-3_bib275","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00213-010-1980-y","article-title":"A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors","volume":"212","author":"Randall-Thompson","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-015-0377-3_bib276","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/fcp.12099","article-title":"Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats","volume":"29","author":"Rahimi","year":"2015","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1007\/s13311-015-0377-3_bib277","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1742-7843.2011.00710.x","article-title":"Adenosine A1, but not A2, receptor blockade increases anxiety and arousal in Zebrafish","volume":"109","author":"Maximino","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1007\/s13311-015-0377-3_bib278","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1172\/JCI62378","article-title":"Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia","volume":"122","author":"Shen","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-015-0377-3_bib279","first-page":"31","article-title":"COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence","volume":"11","author":"M\u00fcller","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1007\/s13311-015-0377-3_bib280","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/mp.2012.90","article-title":"Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure","volume":"18","author":"Hill","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-015-0377-3_bib281","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1007\/s13311-015-0377-3_bib282","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12011-014-9960-4","article-title":"Diphenyl ditelluride induces anxiogenic-like behavior in rats by reducing glutamate uptake","volume":"158","author":"Stangherlin","year":"2014","journal-title":"Biol Trace Elem Res"},{"key":"10.1007\/s13311-015-0377-3_bib283","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings","volume":"38","author":"Morgan","year":"2013","journal-title":"Addict Behav"},{"key":"10.1007\/s13311-015-0377-3_bib284","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0377-3_bib285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2012.01.030","article-title":"The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats","volume":"1444","author":"Adamczyk","year":"2012","journal-title":"Brain Res"},{"key":"10.1007\/s13311-015-0377-3_bib286","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104546","article-title":"Blocking TRPV1 in nucleus accumbens inhibits persistent morphine conditioned place preference expression in rats","volume":"9","author":"Heng","year":"2014","journal-title":"PloS One"},{"key":"10.1007\/s13311-015-0377-3_bib287","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.celrep.2013.07.002","article-title":"Opiates modulate thermosensation by internalizing cold receptor TRPM8","volume":"4","author":"Shapovalov","year":"2013","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-015-0377-3_bib288","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00008571-199710000-00006","article-title":"Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence","volume":"7","author":"Tyndale","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1007\/s13311-015-0377-3_bib289","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1046\/j.1471-4159.2002.01069.x","article-title":"Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics","volume":"82","author":"Miksys","year":"2002","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-015-0377-3_bib290","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1017\/S1461145709990848","article-title":"Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)","volume":"13","author":"Tournier","year":"2010","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0377-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-015-0377-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0377-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:44:18Z","timestamp":1761806658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923008048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":290,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1878747923008048"],"URL":"https:\/\/doi.org\/10.1007\/s13311-015-0377-3","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Targets of Cannabidiol in Neurological Disorders","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-015-0377-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}